MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.50%

Insider Buying (Last 12 Months): $61,921,142.32

Insider Selling (Last 12 Months): $190,339,788.83

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$482.45

▼ -7.28 (-1.49%)

As of 02/3/2026 05:00 PM ET

Days: 30 | 90 | 365

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/26/2026	Carole Huntsman	Insider	Sell	910	$493.78	$449,339.80	9,122
1/26/2026	Rebecca Taub	Director	Sell	647	$492.42	$318,595.74	452,704
1/26/2026	William John Sibold	CEO	Sell	1,577	$492.42	$776,546.34	148,497
1/20/2026	Rebecca Taub	Director	Sell	2,238	$490.77	$1,098,343.26	453,351
1/20/2026	Shannon T. Kelley	General Counsel	Sell	692	$497.36	$344,173.12	8,481
1/9/2026	Paul A. Friedman	Director	Sell	280	$551.24	$154,347.20	187,164
1/9/2026	Paul A. Friedman	Director	Sell	24,520	$522.39	$12,809,002.80	187,164
1/9/2026	Rebecca Taub	Director	Sell	240	$550.33	$132,079.20	455,589
1/9/2026	Rebecca Taub	Director	Sell	18,410	$522.40	$9,617,384.00	455,589
12/10/2025	Paul A. Friedman	Director	Sell	24,800	$552.18	$13,694,064.00	187,164
12/10/2025	Rebecca Taub	Director	Sell	18,650	$552.15	$10,297,597.50	461,044
12/4/2025	William John Sibold	CEO	Sell	2,400	$575.34	$1,380,816.00	150,074
12/2/2025	Mardi Dier	CFO	Sell	4,173	$578.34	$2,413,412.82	10,440
11/21/2025	Carole Huntsman	Insider	Sell	1,958	$553.11	$1,082,989.38	10,032
11/13/2025	Richard S. Levy	Director	Sell	8,500	$520.96	$4,428,160.00	21,197
11/5/2025	Kenneth Bate	Director	Sell	16,575	$484.30	$8,027,272.50	2,627
9/9/2025	William John Sibold	CEO	Sell	7,279	$445.63	$3,243,740.77	102,474
8/21/2025	William John Sibold	CEO	Sell	7,616	$400.18	$3,047,770.88	109,753
8/20/2025	Bros. Advisors Lp Baker	Director	Buy	59,901	$385.16	$23,071,469.16	1,947,968
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	68,618	$364.04	$24,979,696.72	1,859,091
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	37,164	$373.21	$13,869,976.44	1,893,120
8/18/2025	Shannon T. Kelley	General Counsel	Sell	1,304	$367.81	$479,624.24	9,173
8/15/2025	Kenneth Bate	Director	Sell	10,000	$365.20	$3,652,000.00	2,627
8/13/2025	Paul A. Friedman	Director	Sell	129,172	$370.24	$47,824,641.28	187,164
8/12/2025	Paul A. Friedman	Director	Sell	43,605	$355.68	$15,509,426.40	187,164
8/12/2025	Rebecca Taub	Director	Sell	43,263	$355.69	$15,388,216.47	461,044
8/11/2025	Paul A. Friedman	Director	Sell	3,203	$350.27	$1,121,914.81	187,164
8/11/2025	Rebecca Taub	Director	Sell	3,200	$350.24	$1,120,768.00	461,044
7/18/2025	Paul A. Friedman	Director	Sell	1,400	$350.03	$490,042.00	187,164
7/18/2025	Rebecca Taub	Director	Sell	1,000	$350.00	$350,000.00	461,044
7/17/2025	Paul A. Friedman	Director	Sell	2,700	$350.48	$946,296.00	187,164
7/17/2025	Rebecca Taub	Director	Sell	2,657	$350.41	$931,039.37	461,044
7/16/2025	Paul A. Friedman	Director	Sell	26,176	$353.47	$9,252,430.72	187,164
7/16/2025	Rebecca Taub	Director	Sell	26,444	$353.47	$9,347,160.68	461,044
3/5/2025	Robert E. Waltermire	VP	Sell	14,113	$341.32	$4,817,049.16	3,728
2/28/2025	Robert E. Waltermire	VP	Sell	1,227	$341.07	$418,492.89	3,728
2/27/2025	James M. Daly	Director	Sell	15,470	$347.45	$5,375,051.50	1,912
1/24/2025	Carole Huntsman	Insider	Sell	347	$335.24	$116,328.28	10,438
1/24/2025	Rebecca Taub	CMO	Sell	648	$335.24	$217,235.52	456,662
1/24/2025	Robert E. Waltermire	VP	Sell	103	$335.24	$34,529.72	4,955
1/24/2025	William John Sibold	CEO	Sell	1,584	$335.24	$531,020.16	54,303
1/17/2025	Rebecca Taub	CMO	Sell	1,689	$273.41	$461,789.49	457,310
1/17/2025	Robert E. Waltermire	VP	Sell	442	$273.41	$120,847.22	5,058
1/17/2025	Shannon T. Kelley	General Counsel	Sell	277	$273.41	$75,734.57	7,705
12/3/2024	Fred B. Craves	Director	Sell	3,600	$315.31	$1,135,116.00	11,000
11/25/2024	Fred B. Craves	Director	Sell	3,400	$350.30	$1,191,020.00	14,600
11/1/2024	Richard S. Levy	Director	Sell	5,000	$300.94	$1,504,700.00	11,012
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2026	F m Investments LLC	5,738	$3.34M	0.1%	-9.2%	0.025%
2/2/2026	Truist Financial Corp	569	$0.33M	0.0%	-5.6%	0.003%
2/2/2026	Strs Ohio	3,300	$1.92M	0.0%	+50.0%	0.015%
2/2/2026	Danske Bank A S	200	$0.12M	0.0%	N/A	0.001%
2/2/2026	Oppenheimer & Co. Inc.	392	$0.23M	0.0%	N/A	0.002%
2/2/2026	Oppenheimer Asset Management Inc.	1,313	$0.77M	0.0%	+18.7%	0.006%
1/30/2026	Verity Asset Management Inc.	1,158	$0.67M	0.3%	-8.1%	0.005%
1/30/2026	State of New Jersey Common Pension Fund D	5,044	$2.94M	0.0%	-3.5%	0.022%
1/30/2026	Moody Aldrich Partners LLC	3,876	$2.26M	0.4%	N/A	0.017%
1/30/2026	Torren Management LLC	155	$90K	0.0%	N/A	0.001%
1/30/2026	M&T Bank Corp	629	$0.37M	0.0%	N/A	0.003%
1/29/2026	D.A. Davidson & CO.	2,129	$1.24M	0.0%	+2.8%	0.009%
1/29/2026	Pictet Asset Management Holding SA	181,949	$106.02M	0.1%	-5.1%	0.801%
1/29/2026	UBS Group AG	102,641	$59.77M	0.0%	-52.8%	0.452%
1/29/2026	Sanctuary Advisors LLC	1,371	$0.80M	0.0%	-6.4%	0.006%
1/29/2026	Vanguard Group Inc.	1,808,894	$1.05B	0.0%	-0.2%	7.965%
1/29/2026	Calamos Advisors LLC	6,566	$3.82M	0.0%	+46.4%	0.029%
1/29/2026	China Universal Asset Management Co. Ltd.	3,701	$2.16M	0.2%	-5.3%	0.016%
1/28/2026	Arizona State Retirement System	4,040	$2.35M	0.0%	-5.1%	0.018%
1/28/2026	Chicago Partners Investment Group LLC	961	$0.56M	0.0%	-6.2%	0.004%
1/28/2026	M&T Bank Corp	6,064	$3.53M	0.0%	N/A	0.027%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	19,076	$11.11M	0.0%	+24.8%	0.084%
1/27/2026	Cannon Global Investment Management LLC	700	$0.41M	1.0%	-12.5%	0.003%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	2,978	$1.73M	0.0%	+40.3%	0.013%
1/27/2026	GF Fund Management CO. LTD.	445	$0.26M	0.0%	-7.3%	0.002%
1/26/2026	JGP Global Gestao de Recursos Ltda.	625	$0.36M	0.2%	-40.0%	0.003%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	50,631	$29.48M	0.1%	+0.1%	0.223%
1/26/2026	CWM LLC	1,875	$1.09M	0.0%	-20.6%	0.008%
1/23/2026	Farther Finance Advisors LLC	140	$82K	0.0%	+34.6%	0.001%
1/23/2026	Assetmark Inc.	4,810	$2.80M	0.0%	-4.9%	0.021%
1/23/2026	AMI Asset Management Corp	2,752	$1.60M	0.1%	-19.7%	0.012%
1/23/2026	Valley National Advisers Inc.	161	$93K	0.0%	+312.8%	0.001%
1/23/2026	James J. Burns & Company LLC	532	$0.31M	0.0%	N/A	0.002%
1/23/2026	Choreo LLC	381	$0.22M	0.0%	N/A	0.002%
1/21/2026	Rheos Capital Works Inc.	26,215	$15.27M	1.0%	-39.3%	0.115%
1/21/2026	Flagship Harbor Advisors LLC	50	$29K	0.0%	N/A	0.000%
1/21/2026	Newbridge Financial Services Group Inc.	3,548	$2.07M	0.3%	-2.6%	0.016%
1/21/2026	Capricorn Fund Managers Ltd	6,600	$3.84M	0.9%	N/A	0.029%
1/20/2026	Toth Financial Advisory Corp	2,000	$1.17M	0.1%	N/A	0.009%
1/16/2026	Tema Etfs LLC	1,571	$0.92M	0.1%	-3.1%	0.007%
1/15/2026	Allspring Global Investments Holdings LLC	631	$0.38M	0.0%	N/A	0.003%
1/15/2026	J. Safra Sarasin Holding AG	1,546	$0.90M	0.0%	-35.5%	0.007%
1/14/2026	Hennion & Walsh Asset Management Inc.	8,163	$4.75M	0.2%	-36.5%	0.036%
1/14/2026	Eastern Bank	86	$50K	0.0%	+32.3%	0.000%
1/12/2026	Peak Financial Advisors LLC	4,466	$2.60M	1.2%	+287.0%	0.020%
1/9/2026	SG Americas Securities LLC	6,386	$3.72M	0.0%	+23.0%	0.028%
1/9/2026	Assenagon Asset Management S.A.	5,390	$3.14M	0.0%	N/A	0.024%
1/8/2026	Wealth Enhancement Advisory Services LLC	1,513	$0.84M	0.0%	+113.7%	0.007%
1/7/2026	Aventura Private Wealth LLC	62	$36K	0.0%	N/A	0.000%
1/7/2026	Everhart Financial Group Inc.	1,163	$0.68M	0.1%	+153.4%	0.005%
1/5/2026	Park Avenue Securities LLC	858	$0.50M	0.0%	+9.2%	0.004%
1/5/2026	GAMMA Investing LLC	138	$80K	0.0%	+53.3%	0.001%
1/1/2026	JPMorgan Chase & Co.	47,824	$21.94M	0.0%	-14.4%	0.211%
12/2/2025	Swiss Life Asset Management Ltd	646	$0.30M	0.0%	N/A	0.003%
12/1/2025	Groupama Asset Managment	27,444	$12.59M	0.0%	-32.9%	0.121%
11/21/2025	CIBC Bancorp USA Inc.	1,983	$0.91M	0.0%	N/A	0.009%
11/20/2025	Centaurus Financial Inc.	709	$0.33M	0.0%	+5.0%	0.003%
11/19/2025	Coldstream Capital Management Inc.	512	$0.24M	0.0%	N/A	0.002%
11/18/2025	Kozak & Associates Inc.	424	$0.19M	0.0%	+30.9%	0.002%
11/18/2025	Integrated Investment Consultants LLC	567	$0.26M	0.0%	N/A	0.002%
11/17/2025	Abel Hall LLC	590	$0.27M	0.1%	N/A	0.003%
11/17/2025	Castleark Management LLC	9,926	$4.55M	0.1%	N/A	0.044%
11/17/2025	Woodline Partners LP	103,847	$47.63M	0.2%	-34.9%	0.457%
11/17/2025	Dark Forest Capital Management LP	1,259	$0.58M	0.0%	N/A	0.006%
11/17/2025	PharVision Advisers LLC	582	$0.27M	0.2%	N/A	0.003%
11/17/2025	University of Wisconsin Foundation	13,007	$5.97M	5.1%	-73.1%	0.057%
11/17/2025	Verition Fund Management LLC	5,630	$2.58M	0.0%	+30.3%	0.025%
11/17/2025	Verity Asset Management Inc.	1,260	$0.58M	0.2%	-26.6%	0.006%
11/17/2025	Steadfast Capital Management LP	29,800	$13.67M	0.2%	N/A	0.131%
11/17/2025	Scientech Research LLC	634	$0.29M	0.1%	N/A	0.003%
11/17/2025	Polar Capital Holdings Plc	265,154	$121.62M	0.6%	+17.6%	1.168%
11/17/2025	Quarry LP	86	$39K	0.0%	N/A	0.000%
11/17/2025	Qube Research & Technologies Ltd	2,588	$1.19M	0.0%	-32.7%	0.011%
11/17/2025	Northern Trust Corp	159,988	$73.38M	0.0%	+12.0%	0.704%
11/17/2025	Mariner LLC	1,821	$0.84M	0.0%	+17.5%	0.008%
11/17/2025	Millennium Management LLC	1,798	$0.83M	0.0%	-83.4%	0.008%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	11,356	$5.19M	0.0%	-9.1%	0.050%
11/17/2025	Iron Triangle Partners LP	58,378	$26.78M	3.8%	N/A	0.257%
11/17/2025	HighVista Strategies LLC	3,537	$1.62M	0.4%	+53.4%	0.016%
11/17/2025	First Light Asset Management LLC	11,539	$5.29M	0.5%	N/A	0.051%
11/17/2025	Brevan Howard Capital Management LP	1,375	$0.63M	0.0%	+17.9%	0.006%
11/17/2025	Cinctive Capital Management LP	3,606	$1.65M	0.1%	-24.4%	0.016%
11/17/2025	Baker BROS. Advisors LP	2,141,701	$982.31M	7.1%	+8.4%	9.430%
11/17/2025	Bamco Inc. NY	2,600	$1.19M	0.0%	N/A	0.011%
11/17/2025	California Public Employees Retirement System	24,097	$11.05M	0.0%	-12.6%	0.106%
11/17/2025	Bank of America Corp DE	244,292	$112.05M	0.0%	-11.9%	1.076%
11/17/2025	Boothbay Fund Management LLC	1,117	$0.51M	0.0%	N/A	0.005%
11/17/2025	Ally Bridge Group NY LLC	32,662	$14.98M	9.1%	N/A	0.144%
11/17/2025	ArrowMark Colorado Holdings LLC	123,259	$56.53M	1.0%	-14.9%	0.543%
11/17/2025	Algert Global LLC	8,030	$3.68M	0.1%	-15.7%	0.035%
11/17/2025	Alkeon Capital Management LLC	120,000	$55.04M	0.1%	N/A	0.528%
11/17/2025	Alliancebernstein L.P.	35,695	$16.37M	0.0%	+68.0%	0.157%
11/17/2025	Ameriprise Financial Inc.	12,997	$5.96M	0.0%	+54.6%	0.057%
11/14/2025	Creative Planning	8,430	$3.87M	0.0%	+63.3%	0.037%
11/14/2025	Raymond James Financial Inc.	70,584	$32.37M	0.0%	+28.5%	0.311%
11/14/2025	Bellevue Group AG	2,393	$1.10M	0.0%	+117.5%	0.011%
11/14/2025	Man Group plc	21,328	$9.78M	0.0%	+1,460.2%	0.094%
11/14/2025	California State Teachers Retirement System	13,891	$6.37M	0.0%	-1.7%	0.061%
11/14/2025	ADAR1 Capital Management LLC	4,895	$2.25M	0.2%	+364.4%	0.022%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	23,476	$10.77M	0.0%	-41.0%	0.103%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $482.45

$467.86

$491.29

50 Day Range

MA: $549.44

$480.45

$603.56

52 Week Range

Now: $482.45

$265.00

$615.00

Volume

339,921 shs

Average Volume

341,244 shs

Market Capitalization

$10.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Richard S Levy (Director)
Mardi Dier (CFO)
Carole Huntsman (Insider)
Shannon T Kelley (General Counsel)
Robert E Waltermire (VP)
Kenneth Bate (Director)
James M Daly (Director)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 7.97%
Pictet Asset Management Holding SA — 0.80%
UBS Group AG — 0.45%
Mirae Asset Global Investments Co. Ltd. — 0.22%
Rheos Capital Works Inc. — 0.12%
Universal Beteiligungs und Servicegesellschaft mbH — 0.08%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
UBS Group AG
Rheos Capital Works Inc.
Pictet Asset Management Holding SA
Hennion & Walsh Asset Management Inc.
Vanguard Group Inc.
J. Safra Sarasin Holding AG
AMI Asset Management Corp
F m Investments LLC
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Richard S Levy (Director)
Mardi Dier (CFO)
Carole Huntsman (Insider)
Shannon T Kelley (General Counsel)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
IMC Chicago LLC
Capricorn Fund Managers Ltd
M&T Bank Corp
Assenagon Asset Management S.A.
Moody Aldrich Partners LLC
Universal Beteiligungs und Servicegesellschaft mbH
Peak Financial Advisors LLC
Calamos Advisors LLC